Submitted by Anonymous (not verified) on 25 July 2025 - 14:50
Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Date of authorisation: 13/02/2017, Revision: 23, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Date of authorisation: 13/02/2017, Revision: 23, Status: Authorised